Source: Dongguan Time Network - iDongguan
At the comprehensive launch event of the Greater Bay Area Comprehensive National Science Center Pilot Launch Zone (Songshan Lake Science City) held last week, two universities laid the foundation, 18 academicians were hired, and 8 scientific and technological innovation projects were signed, and source innovation and technological innovation opened up a new situation and embarked on a new journey.
Bioindustry is one of the key breakthrough industries in Songshan Lake Science City. As the never-ending Chaoyang industry, after years of development, Songshan Lake has settled in more than 400 biotechnology companies, and the concentration of medical devices, biomedicine and health care products is obvious and has begun to take shape.
"Songshan Lake Science City is fully launched, and will accelerate the gathering of scientific and technological resources such as talents and help the development of Dongguan bioindustry. Dongguan Biotechnology Company will accelerate the formation of a full-process vertical ecological system for the R&D, incubation, pilot production, clinical registration, and industrialization of the bioindustry through multiple measures such as grasping the leading, strengthening the stock, building a platform, attracting incremental volume, making up for shortcomings, promoting development, building a center, and full service. "Song Tao, president of the Dongguan Biotechnology Industry Association, consulting with Dongguan Institute of Technology, and chairman of Dongguan Biotechnology Industry Development Co., Ltd. (hereinafter referred to as "Biotechnology Company").
Biotechnology Industry Building - Songhu Pharmaceutical Port Industrial Park Project rendering
Welcome the bonus period:
Science City is launched, accelerating the gathering of scientific and technological innovation resources such as talents
Two universities are laid, 18 academicians are hired, and 8 scientific and technological innovation projects are signed... A rising science city is inseparable from large scientific and technological installations with innovation, the university where talents gather, and the fertile industrial soil.
Bioindustry is one of the seven major industries that Songshan Lake Science City has key breakthroughs and built. In the "Several Opinions on Accelerating the Construction of the Pilot Launch Zone of the Greater Bay Area Comprehensive National Science Center (Songshan Lake Science City)" (hereinafter referred to as the "Opinions"), reviewed and passed in September last year, it was proposed that Songshan Lake Science City will focus on seven major industries including biomedicine, relying on major scientific and technological infrastructure and cutting-edge basic research platforms, build a number of new collaborative innovation platforms and industrial innovation alliances, and carry out concentrated research on core technologies.
Dongguan, a famous manufacturing city, has officially decided to build the "Dongguan Cross-Strait Biotechnology Industry Cooperation Base" in the second half of 2012. After years of development, the bioindustry has begun to take shape and has achieved quantitative accumulation from scratch.
What development advantages will Songshan Lake Science City bring to Dongguan’s biological industry?
As early as August last year, the first industrialization project produced by the -related technology of spalling neutron source in China, accelerator boron neutron capture treatment (hereinafter referred to as "BNCT") produces strong neutron beams and irradiates tumors with neutrons. This is also the first experimental device for the accelerator boron neutron capture treatment independently developed by my country.
With the orderly advancement of accelerator boron neutron capture treatment, in the future, BNCT treatment centers will generate new momentum while benefiting patients across the country, and accelerate the development of Dongguan's high-end medical device industry.
"Dongguan accelerates the construction of BNCT treatment centers and conducts clinical trials as soon as possible, which is of great significance to benefit patients and enhance the influence of domestic BNCT." Fu Shinian, deputy manager of China's spall neutron source engineering, believes. The construction of
large scientific device is based on 10 years. China's Spallation Neutron Source, which started construction in 2011, has provided strong scientific and technological research and development strength for the development of Dongguan's biological industry and provided development advantages that most cities cannot match. This shows the role of the large scientific device in promoting the development of the biotechnology industry. The "Opinions" proposes that we should rely on large scientific devices to lay out cutting-edge cross-research platforms and scientific and technological basic support service platforms, accelerate the construction of projects such as neutron therapy technology exploration facilities, large scientific intelligent computing data centers, Greater Bay Area electron microscope centers, materials science user experimental facilities, etc., form a chain collaboration between large scientific devices and cutting-edge technology research and development, provide support for key technological breakthroughs in the industry, and give birth to more major innovative achievements from "0" to "1".
With the full launch of the pilot launch area of the Greater Bay Area Comprehensive National Science Center (Songshan Lake Science City), the prospects presented in the future are even more exciting.
During the launch event, the Greater Bay Area University (Songshan Lake Campus) and the City University of Hong Kong (Dongguan) laid the foundation on the same day. While changing the education pattern of Dongguan, the two high-level universities also brought predictable development opportunities to the development of the industry.
It is understood that City University of Hong Kong (Dongguan) will establish four colleges including the School of Medicine and Life Sciences. This will strengthen the shortcomings in talent resources in the future for the high-tech biological industry.
and Greater Bay Area University mainly builds major scientific devices and new R&D institutions related to the comprehensive National Science Center to integrate school-run disciplines, establish graduate schools and research institutes in related fields, and undertakes related functions of industry, academia and research.
Just last week, the 2021 Songshan Lake Science and Technology Frontier Forum, hosted by Dongguan Institute of Technology and co-organized by Songshan Lake Management Committee and Dongguan Science and Technology Bureau, was grandly held. 11 major projects and platforms including the biological industry were unveiled and participated in the construction of Songshan Lake Science City. During the seminar, Song Tao and other experts jointly discussed the feasibility suggestions and future development of Dongguan University of Technology in building the School of Life and Health Technology.
Discussion on the establishment of the School of Life and Health Technology is a vivid manifestation of Dongguan's biological industry taking the initiative and seizing opportunities when the Songshan Lake Science City is fully launched.
"After years of development, Dongguan's biological industry has begun to take shape. With the implementation of the national strategy in Dongguan, Songshan Lake Science City has been fully launched. In the near future, Dongguan's biological industry will usher in a dividend period of accelerated gathering of scientific and technological innovation resources." Song Tao said in his speech at this forum.
Dong and Taiwan Biotechnology Cooperation Cultivation Center
Create new momentum:
Build new momentum:
Build an important domestic biomedical research and development and manufacturing base
10 years ago, China's spall neutron source officially started construction, and 10 years later, the national strategy of Songshan Lake Science City was fully launched. In 2012, under the demand for industrial development of Dongguan's transformation and upgrading, Dongguan officially entered the biological industry.
Nearly 10 years have passed, and with the support of the municipal party committee and government, Dongguan Biotechnology Company has already begun to take shape in promoting the development of the biological industry from "0" to "1", from small to large.
It is reported that at present, Songshan Lake Hi-tech Zone has settled in more than 400 biotechnology companies, including the leading domestic innovative drug Dongyangguang Pharmaceutical , the leading biopharmaceutical company Sansheng Pharmaceutical, the largest domestic in vitro diagnostic reagent raw material supplier Feipeng Bio, the drafting and formulation unit of domestic DR (digital X-ray imaging system) industry standards Anjian Technology, the second largest supplier of the global pioneer occluder series products Xianjian Technology, the largest company in the world denture processing industry, the leading company in the domestic high-pressure contour industry, Ante Hi-Tech, and the leading domestic color ultrasound equipment company Kaili Medical, etc.
This is a powerful foundation and driving force for Dongguan’s biological industry to embark on a new journey. This is also an important condition for Songshan Lake biological industry to become one of the strategic emerging industries of Dongguan .
In February this year, the "Implementation Plan for the Planning and Construction of Dongguan Strategic Emerging Industry Bases" (hereinafter referred to as the "Implementation Plan") was released, and Dongguan's biological industry ushered in a new round of development opportunities.
According to the "Implementation Plan", the Songshan Lake Biopharmaceutical Industry Base, with a total planned area of 2,489 mu, will focus on the development of biopharmaceuticals, high-end medical devices, smart medical care and other industries, and build a domestic biopharmaceutical industry base with great potential.
This year, Dongguan has proposed to "create new momentum" for the first time. The first step to grasp new momentum is new industries. Biomedicine is known as the ever-ending sunrise industry, especially since the new crown epidemic, the development of biomedicine industry has become the focus of attention of all parties.
"The coronary balloon developed by Bomai Medical has been included in the list of 20 places in the country." said Li Bin, chairman of Guangdong Bomai Medical Equipment Co., Ltd., located in Songshan Lake.
Bomai Medical, established in Songshan Lake Hi-Tech Zone in 2012, has 9 years of development and has multiple exclusive technologies and products worldwide, and has grown into a leading enterprise in vascular interventional balloon products and technologies in China.Its coronary interventional balloon series products have been exported to more than 50 countries and regions around the world, including developed countries such as the United States, Japan, and Europe.
In the past, disposable high-value consumable products such as coronary balloon catheter guidewires were inverted pattern of import monopoly, with huge potential for import substitution markets, and domestic brands have a long way to go. After Bomai Medical engages in its research and development and production, it has ranked among the top in the domestic brand market share of coronary balloon catheters in just two and a half years.
html The Implementation Plan issued in February clearly states that the Songshan Lake Bio-Pharmaceutical Industry Base is located in the Songshan Lake Triangle and the Taiwan Science and Technology Park part, with a total planned area of 2,489 mu, about 1.66 square kilometers. Its future development goal is to focus on the resource advantages of the national high-tech zone, focus on the development of industries such as biomedicine, high-end medical devices, smart medical care, etc., and build a domestic biomedicine industry base with great potential.The Implementation Plan also proposes to promote the development of large domestic and foreign biological research institutions and enterprises in Dongguan, focus on breaking through innovative drugs, high-end medical devices, smart medical care and other fields, cultivate and strengthen large health and life industry clusters, and build an important domestic biomedical research and development and manufacturing base.
In terms of key development areas, Dongguan will focus on the development of biomedicine, undertake the research and development and production of authorized new drugs overseas, accelerate the development and cultivation of new Chinese medicines and modern new Chinese medicines, and build innovative new drug research and development institutions with local characteristics. Focus on the development of precision medicine and high-end medical devices, and accelerate the research and development and production of digital medical imaging equipment, new medical diagnostic equipment, wearable smart devices and other electronic medical equipment.
In addition, Dongguan will also cultivate and develop the smart medical industry, establish a city medical big data center, and support the innovative application of artificial intelligence in medical big data analysis and diagnosis and treatment.
In terms of benefiting people's livelihood, Dongguan will lay out the research and development of smart medical products such as home self-diagnosis and personal health monitoring wearable devices with networking functions, encourage the development and application of various health-related software, and develop emerging business formats that integrate equipment, medical care, data and services.
builds a new platform:
focuses on building a capital platform and a CRO/CMO platform
policies guide the direction of development, and large scientific devices empower the future of the industry. For the biological industry itself, how can we continue to consolidate the industrial foundation and seize opportunities while facing the siphon effect of the two super cities of Guangzhou and Shenzhen at the same time?
Since Dongguan built the "Dongguan Cross-Strait Biotechnology Industry Cooperation Base", Song Tao, chairman of the State-owned Assets Biotechnology Company, has clear development goals for the future of industrial development.
Leading enterprises are the backbone of industrial development and the main force in driving the optimization and upgrading of the biotechnology industry. They play a very important role in promoting economic growth, driving the development of small and medium-sized enterprises, solving social employment, expanding the market, promoting transformation and upgrading, and enhancing the regional image.
htmlOn April 7, Dongguan Biotechnology Company, together with Dongguan Songshan Lake Science City Development Group Co., Ltd., held a project signing ceremony with Guangdong Dongyangguang Pharmaceutical Co., Ltd. . The latter two invested in Guangdong Dongyangguang Pharmaceutical Co., Ltd. to help Songshan Lake biopharmaceutical leading enterprises accelerate their growth.This is a vivid case of the state-owned Dongguan company promoting the development of Dongguan's biological industry. Before this, due to the high overall financing amount of Guangdong Dongyangguang Pharmaceutical, the leading company in Songshan Lake, the company's leading company, has a high degree of difficulty in completing it. Dongguan Biotechnology Company's move helped the company to go public in the future to realize the securitization of pharmaceutical assets.
As the supplier of core raw materials and solutions for in vitro diagnostic reagents with the largest market share in China, Feipeng Bio is a high-tech enterprise specializing in the research and development, production of core raw materials for in vitro diagnostic reagents and providing customers with one-stop solutions.
"Fipeng Bio has taken root in Dongguan since 2016. Songshan Lake Management Committee and Dongguan Biotechnology Company have provided thoughtful and meticulous services for the company's implementation and development. It has achieved rapid development results, and its revenue is expected to be around 500 million in 2020, and it is showing a rapid development trend in Songshan Lake, Dongguan."Ou Gaobing, general manager of Feipeng Biology, said that upstream and downstream enterprises around Songshan Lake are accelerating their gathering and are optimistic about the future development of Songshan Lake's biological industry. "Dongguan Biology Company will continue to provide impetus for promoting the development of the biopharmaceutical industry through multiple measures such as focusing on the leading position, strengthening the stock, building platforms, and attracting incremental volumes. "Song Tao said that at present, Songshan Lake has more than 20 land purchase companies, which are the leaders in various sub-sectors. Dongguan Biotechnology Company will focus on serving these leading companies, assist in solving various difficulties in their development process, and promote them to a higher level of development.
In addition, in terms of small and medium-sized enterprises, Dongguan Biotechnology Company will select and focus on cultivating 10-20 innovative enterprises with great growth potential and fast development speed based on innovative small and micro enterprises, growth-oriented small and medium-sized enterprises, and high-tech enterprises, increase corporate support, and strive to cultivate a group of industry backbone enterprises and unicorns in the field of biomedicine that masters core key technologies and strong independent innovation capabilities.
Biotechnology Company is a typical high-tech industry. "This year, Dongguan Biotechnology Company will focus on building the park's capital platform and CRO/CMO platform (R&D outsourcing/production outsourcing). In terms of capital platform, we will take the lead in establishing a biopharmaceutical industry fund with a scale of 4 billion yuan, focusing on investing in innovative biotechnology enterprises that have settled in or are about to settle in Songshan Lake to accelerate the development of enterprises. "Song Tao said that Dongguan and Songshan Lake are currently raising an industrial fund of 10 billion yuan, which is expected to expand to 50 billion yuan by leveraging social capital. These funds will focus on investing in seven strategic emerging industries in Dongguan, including the biological industry, providing strong capital support for the development of the biological industry.
In terms of public service platforms, this year, Dongguan Biotechnology Company will focus on building three major public service platforms such as preclinical and clinical CRO of pharmaceuticals, pharmaceutical CMO/CDMO, and medical device clinical CRO. At present, Dongguan Biotechnology Company is in the process of outstanding performance in the above fields. Listed companies negotiate cooperation plans. After the three major platforms are completed, the core industries of medicine and medical devices from R&D to production can be opened.
opens the entire chain:
accelerates the formation of a full-process vertical ecological system of the biological industry
Songshan Lake Bioindustry has achieved a breakthrough from "0" to "1", how to promote the industry to take off from "1" to "100". "Dongguan Biotechnology Company will make up for the shortcomings from industry value chain , talents, policies and other angles. At the same time, the formation of a vertical ecological system for the entire process of biological industry research and development, incubation, pilot production, clinical registration and industrialization will be accelerated. "Song Tao said.
In terms of industrial value chain, Dongguan will carefully sort out the industrial chain of existing biological enterprises, find key links and missing links of existing industrial chains, and promote the deep integration and development of the entire industrial chain by strengthening the allocation of key links.
At the same time, combined with the advantages of Dongguan information technology, Dongguan Biotechnology Company will promote the cross-border integration and development between the industrial chains, and actively promote the cross-border integration and development of "medical + intelligent machines", "medical + big data", "medical + mobile Internet". For example, Dongguan Biotechnology Company is currently promoting the cooperation between Jinyu Medical Dongguan project and Huawei in medical + big data, and promote the intelligence and efficiency of pathological detection and analysis.
In addition, in terms of talents, Dongguan Biotechnology Company will continue to strengthen its cooperation with local universities, especially It is a cooperation between Dongguan Institute of Technology to strengthen the cultivation of basic and applied talents in biotechnology and provide high-quality talents for industrial development. Chairman Song Tao of Dongguan Biotechnology Company has been hired as an advisor to Dongguan Institute of Technology. He will be committed to the construction of the biotechnology industry-university-research platform in the field of biotechnology, and establish a communication bridge between school talents and enterprises. In terms of the industrial ecosystem, Dongguan Biotechnology Company will work with the Biotechnology Industry Association to jointly build a biotechnology enterprise, universities, research institutes and service institutions in Guangzhou and Shenzhen to build a biotechnology industry cooperation alliance in the Guangzhou and Shenzhen Science and Technology Corridor, promote technology exchange, resource sharing, and talent circulation within the alliance, and form a healthy and vibrant industrial environment.
Nothing bluntly, the Songshan Lake biotechnology industry has completed the basic agglomeration in the early stage, but the distribution is still relatively scattered, and no professional parks or service centers have been formed.
"Songshan Lake Biopharmaceutical Industry Base has been officially listed. In the next step, we will build a professional park and service center for Songshan Lake Biopharmaceutical Industry, and build a vertical ecological system for the entire process of biological industry research and development, incubation, pilot production, clinical registration, and industrialization. It will be the enterprise center, display center, public service supporting center, conference exchange center and government service center of Songshan Lake Biopharmaceutical Industry, and become the source of the park's development of the biological industry." Song Tao said.
It is understood that Songshan Lake Biomedical Industry Base's professional park - Songhu Medicine Port covers an area of 167 mu, with a total construction area of nearly 400,000 square meters, creating an ecological technology and garden-style Dongguan Bioindustry Center Park.
In the future, Dongguan Biotechnology Company will rely on large scientific devices such as Spallation Neutron Source, first-class platforms and enterprises such as Huawei, Dongyangguang , to gather more high-end and high-level professional talents, build a platform for scientists to communicate, connect and cooperate with entrepreneurs, strengthen professional industrial services such as registration and declaration, intellectual property, and marketing, and accelerate the operation of the entire life cycle of the biological industry chain.
Text: Zhang Huaqiao
Photography: Photo provided by the interviewed unit
Editor: Fu Deming
This article comes from [Dongguan Time Network-i Dongguan] and only represents the author's views. The National Party Media Information Public Platform provides information release and dissemination services.
